Clinical Report: Efficacy of Intermittent Theta-Burst Stimulation on Depressive Symptoms

Overview

This randomized, double-blind, sham-controlled trial evaluates the antidepressant effects of intermittent theta-burst stimulation (iTBS) in adults with major depressive disorder (MDD).

Background

Major depressive disorder (MDD) is a significant global health concern, often leading to disability and inadequate response to traditional treatments. Repetitive transcranial magnetic stimulation (rTMS) has been established as an effective treatment for MDD, with intermittent theta-burst stimulation (iTBS) emerging as a time-efficient alternative. The clinical adoption of iTBS has increased since its regulatory approval in 2018, yet further research is necessary to clarify its specific effects compared to sham treatments.

Data Highlights

No numerical data provided in the source material.

Key Findings

• The study was a randomized, double-blind, sham-controlled trial comparing iTBS to sham stimulation in adults with MDD.
• Participants received 10 sessions of iTBS delivered to the left dorsolateral prefrontal cortex (DLPFC).
• Inclusion criteria included adults aged 22-65 years with a MADRS score of 20 or more and low suicide risk.
• The trial adhered to ethical guidelines and was registered in ClinicalTrials.org.
• Follow-up assessments were conducted via telephone 4 weeks post-treatment.

Clinical Implications

The findings from this trial may inform clinicians about the potential efficacy of iTBS as a treatment option for patients with MDD who have not responded adequately to other therapies. Understanding the specific effects of iTBS compared to sham stimulation is crucial for optimizing treatment strategies.

Conclusion

This study adds to the evidence supporting the use of iTBS in treating MDD, highlighting its potential as an effective intervention in clinical settings.

Related Resources & Content

1. JAMA Network Open, 2023 -- Intermittent Theta-Burst Stimulation and Depressive Symptoms in Major Depressive Disorder: A Randomized Clinical Trial
2. JAMA Network Open, 2023 -- Intermittent Theta-Burst Stimulation for Depression—Delineating Specific and Nonspecific Effects
3. JAMA Network Open, 2023 -- Intermittent Theta-Burst Stimulation for Depressive Symptoms in Parkinson Disease: A Randomized Clinical Trial
4. Conexiant, 2023 -- Comparing Brain Stimulation Strategies for Depression
5. Mental Health Clinical Practice Guidelines - VA/DOD Clinical Practice Guidelines, 2026
6. BMC Psychiatry (Springer) — Impact of Enhanced Intermittent Theta Burst Stimulation on Depressive Symptoms and Cognitive Abilities in Adolescents with Bipolar Disorder
7. Consensus Review and Considerations on TMS to Treat Depression
8. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D)
9. Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression
10. Mental Health Clinical Practice Guidelines - VA/DOD Clinical Practice Guidelines
11. Intermittent Theta-Burst Stimulation and Depressive Symptoms in Major Depressive Disorder: A Randomized Clinical Trial | Medical Devices and Equipment | JAMA Network Open | JAMA Network
12. Frontiers | Efficacy and safety of intermittent theta-burst stimulation versus continuous theta-burst stimulation for major depressive disorder and bipolar depression: a systematic review